End-of-day quote
Shanghai S.E.
07:00:00 2024-03-27 pm EDT
5-day change
1st Jan Change
56.99
CNY
-2.91%
-6.39%
-0.04%
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Year 2018
Autobio Diagnostics Co., Ltd. reported earnings results for the year 2018. For the year, the company reported basic earnings per share of CNY 1.34.
Autobio Diagnostics Gets Regulatory Nod in China for 16 Devices
Feb. 23
MT
Autobio Diagnostics Co., Ltd. commences an Equity Buyback Plan for CNY 500 million worth of its shares, under the authorization approved on February 20, 2024.
Feb. 20
CI
Autobio Diagnostics Co., Ltd. authorizes a Buyback Plan.
Jan. 28
CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-25
CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to S&P Global BMI Index
23-09-18
CI
Autobio Diagnostics Logs Low Single-Digit Earnings Growth in H1
23-08-18
MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-17
CI
Autobio Diagnostics Gets Registration Certificates for Five Devices
23-05-24
MT
Shenzhen Meili Namikong Technology Co., Ltd. announced that it has received funding from Autobio Diagnostics Co., Ltd.
23-04-25
CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-20
CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-04-20
CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to FTSE All-World Index
23-03-20
CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.
23-03-17
CI
Autobio Diagnostics Co., Ltd.'s Equity Buyback announced on March 19, 2022, has closed with 5,260,910 shares, representing 0.90% for CNY 243.27 million.
23-03-16
CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.
23-01-03
CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-25
CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.
22-10-10
CI
Autobio Diagnostics Secure Nine Registration Certificates in China
22-09-27
MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-10
CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.
22-07-01
CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) dropped from S&P Global BMI Index
22-06-20
CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) dropped from FTSE All-World Index
22-06-13
CI
Autobio Diagnostics Co., Ltd.(SHSE:603658) dropped from SSE 180 Index
22-06-10
CI
Autobio Diagnostics Co., Ltd.(SHSE:603658) dropped from Shanghai Stock Exchange 180 Value Index
22-06-10
CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-26
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
More about the company
Last Close Price
56.99
CNY
Average target price
60.64
CNY
Spread / Average Target
+6.41%
Consensus
1st Jan change
Capi.
-0.04% 4.72B -13.95% 8.1B -4.01% 5.13B -32.93% 4.4B +0.39% 4.14B +16.88% 2.82B +3.24% 2.55B +11.39% 1.92B +1.28% 1.65B -2.46% 1.52B
Diagnostic & Testing Substances
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1